Bayesian Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$15.5M |
| 2 |
PayPal
PYPL
|
+$11.8M |
| 3 |
Cisco
CSCO
|
+$10.9M |
| 4 |
Chevron
CVX
|
+$9.4M |
| 5 |
General Motors
GM
|
+$9.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$26.6M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$21.5M |
| 3 |
Microsoft
MSFT
|
+$18.2M |
| 4 |
Alibaba
BABA
|
+$16.9M |
| 5 |
CVS Health
CVS
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.4% |
| 2 | Consumer Discretionary | 13.2% |
| 3 | Financials | 11.72% |
| 4 | Healthcare | 11.25% |
| 5 | Industrials | 9.19% |
Similar funds
Bayesian Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Bayesian Capital Management held 1,199 positions worth $1.05B, up 11% from $942M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Bayesian Capital Management deployed $38.7M of net new capital in Q1 2024, opening 495 new positions and adding to 134 existing holdings. Its largest new stake was Oracle: 135,773 shares worth $17.1M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $26.6M trimmed.
- Bayesian Capital Management's largest Q1 2024 buy was Oracle: 135,773 shares worth $17.1M.
- Bayesian Capital Management added most to Chevron in Q1 2024, an estimated $9.4M increase.
- Bayesian Capital Management's biggest Q1 2024 reduction was Qualcomm, cutting an estimated $26.6M.
- Bayesian Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2024, selling an estimated $21.5M.
- Bayesian Capital Management's ten largest holdings make up 11% of its $1.05B portfolio in Q1 2024.
- Bayesian Capital Management opened 495 new positions and closed 452 in Q1 2024.
- Bayesian Capital Management's portfolio value rose 11% quarter-over-quarter to $1.05B.
Based on Bayesian Capital Management's 13F filing for Q1 2024, filed 15 May 2024.